ClinicalTrials.govpublic full text
CIK Cell Therapy for Relapsed or Refractory Acute B-Lymphoblastic Leukemia: Prognostic Impact on Patients With Early CAR-T Cell Dysfunction
b-cell acute lymphoblastic leukemia, acute lymphoblastic leukemia, in relapse, refractory acute lymphoid leukemia
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 261530
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.